A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma

Clin Transl Med. 2021 May;11(5):e419. doi: 10.1002/ctm2.419.

Jiali Lv^{1

2}, Jialin Wang³, Xiaotao Shen⁴, Jia Liu⁵, Deli Zhao⁶, Mengke Wei^{1

2}, Xia Li^{1

2}, Bingbing Fan^{1

2}, Yawen Sun³, Fuzhong Xue^{1

2}, Zheng-Jiang Zhu⁴, Tao Zhang^{1

2}

¹ Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
² Institute for Medical Dataology, Cheeloo College of Medicine, Shandong University, Jinan, China.
³ The Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China.
⁴ Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
⁵ Yanjing Medical College, Capital Medical University, Beijing, China.
⁶ Tumor Preventative and Therapeutic Base of Shandong Province, Feicheng People's Hospital, Feicheng, China.

No abstract available

Publication types